Kryskow P

Psychedelic-Assisted Therapy Graduate Certificate (PaTGC), Vancouver Island University (VIU), Nanaimo, British Columbia, Canada.

18 papers · ORCID

ArticlePsychedelics

Competencies and Ethical Governance for Psychedelic‑Assisted Therapies: A Practice‑Embedded Quality‑Improvement Framework.

Dames S, Williams K, Campbell A +5

Europe PMC2026
ArticlePsilocybin

Learnings from a hybrid communities of practice group therapy model to support psilocybin-assisted therapy for patients with a terminal diagnosis.

Tsang VW, Kryskow P, Watler C +2

Europe PMC2026
ArticlePsilocybin

Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.

Sabé M, Grof P, Sackett NB +24

Europe PMC2026
ArticleKetamine

Barriers and Access to Care for Firefighters With Posttraumatic Stress Disorder Seeking Ketamine-Assisted Therapy: A Qualitative Study.

Tsang VWL, Tsang VWL, Walia T +2

Europe PMC2026
ArticlePsilocybin

Indigenous Knowledge Systems & Psychedelic Science: Towards Ethical and Reciprocal Collaboration.

Magar V, Robbins M, Fernández Lobo Blanco ÓML +10

Europe PMC2026
ArticlePsilocybin

Improving access to psilocybin-assisted therapy: barriers, challenges, and recommendations.

Tsang VWL, Roney C, Kryskow P +1

Europe PMC2026
ArticlePsilocybin

Psilocybin mitigates chronic behavioral and neurobiological alterations in a rat model of recurrent intimate partner violence-related brain injury.

Allen J, Sun M, Baker TL +5

Europe PMC2026
ArticleKetamine

A clinical protocol for group-based ketamine-assisted therapy in a community of practice: the Roots To Thrive model.

Dames S, Kryskow P, Tsang VWL +1

Europe PMC2025
ArticleKetamine

The effect of the Apollo Neuro device on anxiety among participants who underwent ketamine assisted therapy.

Tsang VWL, Tao B, Olthuis R +4

Europe PMC2025
ArticleKetamine

Ketamine-assisted therapy within a community of practice: a novel approach to disordered eating.

Jeletzky L, Dames S, Kryskow P +1

Europe PMC2025
ArticleKetamine

The Effect of Ketamine-Assisted Group Therapy on Treatment-Resistant Mental Health Conditions in Firefighters: A Prospective Observational Case Series.

Tsang VW, Tsang VW, Lin MC +2

Europe PMC2025
ArticlePsychedelics

Psychedelic-Assisted Therapy Training: An Argument in Support of Firsthand Experience of Nonordinary States of Consciousness in the Development of Competence.

Dames S, Watler C, Kryskow P +4

Europe PMC2024
ArticlePsilocybin

Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study.

Cavarra M, Mason NL, Kuypers KPC +5

Europe PMC2024
ArticleKetamine

Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketamine-assisted therapy program: a retrospective chart review.

Tsang VWL, Tao B, Dames S +2

Europe PMC2023
ArticlePsychedelics

Analgesic potential of macrodoses and microdoses of classical psychedelics in chronic pain sufferers: a population survey.

Bonnelle V, Smith WJ, Mason NL +5

Europe PMC2022
ArticlePsilocybin

Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.

Rootman JM, Kiraga M, Kryskow P +5

Europe PMC2022
ArticleKetamine

A Cohort-Based Case Report: The Impact of Ketamine-Assisted Therapy Embedded in a Community of Practice Framework for Healthcare Providers With PTSD and Depression.

Dames S, Kryskow P, Watler C

Europe PMC2021
ArticlePsilocybin

Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.

Rootman JM, Kryskow P, Harvey K +6

Europe PMC2021